Literature DB >> 17141195

Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop.

Hong Cheng1, Terri Addona, Hasmik Keshishian, Erik Dahlstrand, Chafen Lu, Marion Dorsch, Zhi Li, Anlai Wang, Timothy D Ocain, Ping Li, Thomas F Parsons, Bruce Jaffee, Yajun Xu.   

Abstract

Interleukin-1 stimulation leads to the recruitment of MyD88, interleukin-1 receptor-associated kinase 1 (IRAK-1) and interleukin-1 receptor-associated kinase 4 (IRAK-4) to the IL-1 receptor. The formation of the IL-1 receptor complex triggers a series of IRAK-1 autophosphorylations, which result in activation. IRAK-4 is upstream of IRAK-1 and may act as IRAK-1 kinase to transmit the signal. To date, there is no upstream kinase reported for IRAK-4; the activation mechanism of IRAK-4 remains poorly understood. Here, for the first time, we report three autophosphorylation sites that are responsible for IRAK-4 kinase activity. LC-MS/MS analysis has identified phosphorylations at T342, T345, and S346, which reside within the activation loop. Site-directed mutants at these positions exhibit significant reductions in the catalytic activity of IRAK-4 (T342A: 57%; T345A: 66%; S346A: 50%). The absence of phosphorylation in kinase-dead IRAK-4 indicates that phosphorylations in the activation loop result from autophosphorylation rather than from phosphorylation by an upstream kinase. Finally, we demonstrate that autophosphorylation is an intramolecular event as wild-type IRAK-4 failed to transphosphorylate kinase-inactive IRAK-4. The present data indicate that the kinase activity of IRAK-4 is dependent on the autophosphorylations at T342, T345, and S346 in the activation loop.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141195     DOI: 10.1016/j.bbrc.2006.11.068

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies.

Authors:  Zhaoyang Li; Kenisha Younger; Ronald Gartenhaus; Ann Mary Joseph; Fang Hu; Maria R Baer; Patrick Brown; Eduardo Davila
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

2.  Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20.

Authors:  Yanbao Xiong; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

3.  Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific manner.

Authors:  Leah Cushing; Wayne Stochaj; Marshall Siegel; Robert Czerwinski; Ken Dower; Quentin Wright; Margaret Hirschfield; Jean-Laurent Casanova; Capucine Picard; Anne Puel; Lih-Ling Lin; Vikram R Rao
Journal:  J Biol Chem       Date:  2014-02-24       Impact factor: 5.157

4.  R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88.

Authors:  Yanbao Xiong; Chang Song; Greg A Snyder; Eric J Sundberg; Andrei E Medvedev
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

5.  Structure-function similarities between a plant receptor-like kinase and the human interleukin-1 receptor-associated kinase-4.

Authors:  Dörte Klaus-Heisen; Alessandra Nurisso; Anna Pietraszewska-Bogiel; Malick Mbengue; Sylvie Camut; Ton Timmers; Carole Pichereaux; Michel Rossignol; Theodorus W J Gadella; Anne Imberty; Benoit Lefebvre; Julie V Cullimore
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

6.  Lipopolysaccharide Regulation of Intestinal Tight Junction Permeability Is Mediated by TLR4 Signal Transduction Pathway Activation of FAK and MyD88.

Authors:  Shuhong Guo; Meghali Nighot; Rana Al-Sadi; Tarik Alhmoud; Prashant Nighot; Thomas Y Ma
Journal:  J Immunol       Date:  2015-10-14       Impact factor: 5.422

7.  Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression.

Authors:  Yanbao Xiong; Fu Qiu; Wenji Piao; Chang Song; Larry M Wahl; Andrei E Medvedev
Journal:  J Biol Chem       Date:  2011-01-10       Impact factor: 5.157

8.  Dynamic cross-talk analysis among TNF-R, TLR-4 and IL-1R signalings in TNFalpha-induced inflammatory responses.

Authors:  Shih-Kuang Yang; Yu-Chao Wang; Chun-Cheih Chao; Yung-Jen Chuang; Chung-Yu Lan; Bor-Sen Chen
Journal:  BMC Med Genomics       Date:  2010-05-24       Impact factor: 3.063

Review 9.  Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer.

Authors:  Andrei E Medvedev
Journal:  J Interferon Cytokine Res       Date:  2013-05-15       Impact factor: 2.607

10.  Augmentation of therapeutic responses in melanoma by inhibition of IRAK-1,-4.

Authors:  Ratika Srivastava; Degui Geng; Yingjia Liu; Liqin Zheng; Zhaoyang Li; Mary Ann Joseph; Colleen McKenna; Navneeta Bansal; Augusto Ochoa; Eduardo Davila
Journal:  Cancer Res       Date:  2012-10-04       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.